Research Projects & Grants

For Profit Organization

  • A Phase I, Randomized, Open-Label, Active Controlled, Multi-Center Pilot Study to Compare Reference to Reference Pharmacodynamics of BOTOX® (onabotulinumtoxinA) in Healthy Subjects. Protocol: MR 103A-0I-IPS-1001. lnformed Consent Form Version Dated 25 November 2022., Role: Investigator, Mylan Pharmaceuticals, (11/2023 - 03/2024) Status: Completed
  • Evaluation of the safety and pharmacodynamic effect of AGN-151607 by measuring the compound muscle action potential (CMAP) of the extensor digitorum brevis ( EDB) muscle following a single injection in healthy subjects. Protocol 1925-101-008, dated 18 August 2017. Informed consent form version dated 30 August 2017, Role: Investigator, Allergan Inc., (08/2018 - 08/2019) Status: Completed

Internal

  • Nerve conduction interest study (NCIS), Role: Investigator, LLU Dept. of Neurology, (06/2024 - 06/2025) Status: Approved
  • Electrodiagnostic findings in patients with botulism: A university medical center experience, Role: Investigator, LLU Dept. of Neurology, (03/2025 - 03/2026) Status: Approved